Skip to main content

Table 3 EOPC and older PDAC tumour characteristics and treatment details

From: Demographic, clinical, and pathological features of early onset pancreatic cancer patients

Tumour Characteristics EOPC (N = 35), % (≤50 years) PDAC (N = 334), % (> 50 years) p value
Resectable    0.015
 Yes 8 (22.9%) 147 (44%)  
 No 27 (77.1%) 186 (56%)  
 Missing 0 1 (0%)  
Location    0.579
 Head/Uncinate 27 (77%) 265 (79%)  
 Body/Tail 8 (23%) 62 (19%)  
 Missing 0 7 (2%)  
Differentiation grade    0.315
 Well 2 (6%) 15 (4%)  
 Moderate 16 (46%) 127 (38%)  
 Poor 12 (34%) 170 (51%)  
 Missing 5 (14%) 22 (7%)  
Stages    0.194
 I 2 (5.8%) 16 (5%)  
 II* 6 (17.1%) 117(34%)  
 III 19 (54.2%) 140 (42%)  
 IV 8 (22.9%) 57 (17%)  
 Missing 0 4 (1%)  
Perineural invasion    0.348
 Yes 12 (34%) 142 (43%)  
 No 23 (66%) 192 (57%)  
Perivascular invasion
 Yes 7 (20%) 122 (37%) 0.051
 No 28 (80%) 212 (63%)  
Chemotherapy/ radiotherapy    0.008
 Yes 21 (60%) 153 (46%)  
 No 5 (14%) 131 (39%)  
 Missing 9 (26%) 50 (15%)  
  1. *Stage II p value = 0.032